ABBV UP: ABBV climbs on strong Q2 | Ezbrisk
By: Ezbrisk
Published:
Anomaly score: 2.3069392881648993
Confidence: 0.75
Market summary
ABBV climbs on strong Q2
Ezbrisk assessment
AbbVie is rallying sharply after posting strong Q2 earnings, with its key immunology drugs Skyrizi and Rinvoq continuing to drive growth, while the broader large-cap pharma sector sees positive sentiment.
Sources: https://finance.yahoo.com/markets/stocks/articles/abbvie-stock-buy-posting-strong-140401980.html, https://www.tikr.com/blog/skyrizi-and-rinvoq-are-growing-24-is-abbvie-stock-still-cheap-at
Verdict ID: bce36c18-449b-4350-8ec9-c8b2476f120d